Single institution experience with peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NET).

623Background: Neuroendocrine tumors (NETs) are rare but increasing in incidence. The only curative treatment is surgery, which in many cases is not an option due to metastatic disease at diagnosis...